These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 6162819)

  • 1. The effect of manipulation of the prostate gland on serum prostate-specific acid phosphatase measured by radioimmunoassay.
    Vihko P; Lukkarinen O; Kontturi M; Vihko R
    Invest Urol; 1981 Mar; 18(5):334-6. PubMed ID: 6162819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of digital rectal examination, flexible cystoscopy and prostatic biopsy on free and total prostate specific antigen, and the free-to-total prostate specific antigen ratio in clinical practice.
    Collins GN; Martin PJ; Wynn-Davies A; Brooman PJ; O'Reilly PH
    J Urol; 1997 May; 157(5):1744-7. PubMed ID: 9112518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of prostatic massage on serum levels of prostatic acid phosphatase and specific antigen].
    Sahin A; Ozen H; Balbay D; Bircan K; Koray Z; Karaagaoglu E; Remzi D
    Bull Cancer; 1992; 79(11):1097-100. PubMed ID: 1284587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Measurement of serum prostatic acid phosphatase (PAP) by Delfia PAP Kit using europium and clinical evaluation in patients with prostate cancer].
    Akimoto S; Ohki T; Ichikawa T; Akakura K; Shimazaki J
    Hinyokika Kiyo; 1994 Nov; 40(11):987-93. PubMed ID: 7530404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tumor markers of prostate cancer--evaluation of serum PAP and PA].
    Miki M
    Gan No Rinsho; 1985 May; 31(6 Suppl):664-9. PubMed ID: 2411965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of digital rectal examination and needle biopsy on serum total and percentage of free prostate specific antigen levels.
    Ornstein DK; Rao GS; Smith DS; Ratliff TL; Basler JW; Catalona WJ
    J Urol; 1997 Jan; 157(1):195-8. PubMed ID: 8976249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-analytical and biological variability of prostatic acid phosphatase and prostate-specific antigen in serum from patients with prostatic pathology.
    Panteghini M; Pagani F; Bonora R
    Eur J Clin Chem Clin Biochem; 1992 Mar; 30(3):135-9. PubMed ID: 1376155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical evaluation of serum prostatic acid phosphatase assay based on the immunoenzymatic method (TZR-516)].
    Ikemoto I; Machida T; Oishi Y; Onishi T; Shirai T; Imanaka K
    Hinyokika Kiyo; 1989 Sep; 35(9):1639-42. PubMed ID: 2479240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of prostatic acid phosphatase and prostate specific antigen as serum markers in carcinoma of the prostate.
    Akdaş A; Simşek F; Ilker Y; Türkeri L; Ercan H
    Int Urol Nephrol; 1993; 25(3):271-8. PubMed ID: 7693607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Improved diagnostic evaluation of prostatic neoplasms using radioimmunoassay for prostatic acid phosphatase].
    Gaca A; Panitz N
    Helv Chir Acta; 1981 Aug; 48(3-4):465-6. PubMed ID: 7287485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experience with prostate-specific antigen in patients with prostatic cancer].
    Romics I; Bach D
    Orv Hetil; 1989 Dec; 130(52):2797-800. PubMed ID: 2481833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in prostate-specific antigen and prostatic acid phosphatase concentration following prostatic examination in benign prostatic hypertrophy and prostate cancer patients.
    Romics I; Galamb L
    Eur Urol; 1992; 21 Suppl 1():83-6. PubMed ID: 1385137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum acid phosphatase in patients with localised prostatic cancer, benign prostatic hyperplasia or normal prostates.
    Salo JO; Rannikko S; Haapiainen R
    Br J Urol; 1990 Aug; 66(2):188-92. PubMed ID: 1697205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The significance of prostatic serum acid phosphatase as a tumor marker in prostatic cancer].
    Hamami G
    Hinyokika Kiyo; 1983 Oct; 29(10):1231-45. PubMed ID: 6085711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostatic acid phosphatase levels (enzymatic method) from completely sectioned, clinically benign, whole prostates.
    Brawn PN; Jay DW; Foster DM; Kuhl D; Speights VO; Johnson EH; Riggs M; Lind ML; Coffield KS; Weaver B
    Prostate; 1996 May; 28(5):295-9. PubMed ID: 8610055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunochemical studies of prostatic acid phosphatase.
    Choe BK; Pontes EJ; McDonald I; Rose NR
    Cancer Treat Rep; 1977; 61(2):201-4. PubMed ID: 68823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radioimmunoassay for prostatic acid phosphatase in human serum. Methodologic aspects (author's transl)].
    Pradalier N; Canal P; Pujol A; Fregevu Y; Soula G
    Ann Biol Clin (Paris); 1982; 40(1):45-50. PubMed ID: 7200750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate-specific acid phosphatase in Nigerian patients with prostate carcinoma.
    Bolarin DM; Badejo OA
    East Afr Med J; 1985 May; 62(5):332-7. PubMed ID: 2412782
    [No Abstract]   [Full Text] [Related]  

  • 19. [What is the use of the radioimmunoassay of prostatic acid phosphatase?].
    Luckacs B; Cohen L; Coloby P; Gattegno B; Michel F; Agnes E; Roland J; Thibault P
    J Urol (Paris); 1985; 91(4):211-4. PubMed ID: 2410516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of radioimmunoassay of human prostate-specific acid phosphatase in the diagnosis and follow-up of therapy in prostatic carcinoma.
    Vihko P; Lukkarinen O; Kontturi M; Vihko R
    Cancer Res; 1981 Mar; 41(3):1180-3. PubMed ID: 7459859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.